A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein

文献类型： 外文期刊

第一作者： Guo, Long-Jun

作者： Guo, Long-Jun;Fu, Yu-Jie;Huang, Li-Ping;Wang, Yi-Ping;Wei, Yan-Wu;Wu, Hong-Li;Liu, Chang-Ming;Fu, Yu-Jie

作者机构：

关键词： Porcine circovirus type 2 (PCV2);Mutant PCV2;Vaccine;PCV2a;PCV2b

期刊名称：VACCINE （ 影响因子：3.641； 五年影响因子：3.816 ）

ISSN：

年卷期：

页码：

收录情况： SCI

摘要： Current commercial PCV2 vaccines are almost based on PCV2a and have been shown to be effective in reducing PCV2a and PCV2b viremia and PCV2-associated lesions and diseases. The recent emergence of novel mutant PCV2 (mPCV2) strains and linkage of mPCV2 with cases of porcine circovirus associated disease (PCVAD) in pig herds have raised concerns over emergence of vaccine-escape mutants and reduced efficacy of PCV2a-based vaccines. The aim of this study was to determine the ability of a commercial PCV2a-based vaccine developed by our laboratory to protect conventional pigs against experimental challenge with mPCV2 at 9 weeks of age. Twenty 4-week-old pigs free of PCV2 infection were randomly divided into four treatment groups with 5 pigs each. Two groups were unvaccinated as positive and negative controls. Another two groups were vaccinated with the commercial PCV2a-based vaccine (PCV2-LG strain, China) at 4 weeks of age and identical booster immunization was conducted 3 weeks post primary immunization. At 9 weeks of age, all pigs except the negative control were challenged with a mutant PCV2b/YJ (mPCV2b/YJ) with two amino acids elongation in capsid protein. The experiment was terminated 28 days after challenge. Under the conditions of this study, vaccinated pigs were protected against PCV2 viremia and lesions whereas unvaccinated pigs were not. Moreover, mPCV2b/YJ infection was demonstrated in positive control and almost all had macroscopic or microscopic lesions consistent with PCVAD while negative control did not develop PCVAD. This study indicates that mPCV2b/YJ infection alone can trigger PCVAD development and that the commercial vaccine (PCV2-LG) is still effective in protecting conventional pigs against the emerging mPCV2b/YJ strain in China. (C) 2015 Published by Elsevier Ltd.

分类号： R392

  • 相关文献

[1]Antigenic subtyping and epitopes' competition analysis of porcine circovirus type 2 using monoclonal antibodies. Saha, Dipongkor,Huang, Liping,Bussalleu, Eva,Lefebvre, David J.,Fort, Maria,Nauwynck, Hans J.,Huang, Liping,Van Doorsselaere, Jan.

[2]Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s. Huang, Liping,Wang, Yiping,Wei, Yanwu,Chen, Dongjie,Liu, Dan,Du, Wenjuan,Xia, Deli,Wu, Hongli,Feng, Li,Liu, Changming.

[3]A multivalent killed whole-cell vaccine induces effective protection against Edwardsiella tarda and Vibrio anguillarum. Sun, Yun,Sun, Li,Liu, Chun-sheng,Sun, Yun.

[4]Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: Subunit vaccine vs DNA vaccine. Sun, Yun,Sun, Li,Sun, Yun,Liu, Chun-Sheng.

[5]Rapid detection of porcine circovirus type 2 by loop-mediated isothermal amplification. Chen, Hao-tai,Zhang, Jie,Sun, De-hui,Chu, Yue-feng,Cai, Xue-peng,Liu, Xiang-tao,Luo, Xue-nong,Liu, Yong-sheng,Liu, Qing. 2008

[6]Loop-mediated isothermal amplification for detection of porcine circovirus type 2. Han, Si,Shi, Jianli,Wu, Jiaqiang,Yuan, Xiaoyuan,Cong, Xiaoyan,Xu, Shaojian,Wu, Xiaoyan,Li, Jun,Wang, Jinbao,Zhou, Shun,Han, Si,Wu, Xiaoyan,Yuan, Xiaoyuan,Li, Jun,Wang, Jinbao. 2011

[7]Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-gamma in mice. Wang, Yi-Ping,Liu, Dan,Guo, Long-Jun,Tang, Qing-Hai,Wei, Yan-Wu,Wu, Hong-Li,Liu, Jian-Bo,Li, Sheng-Bin,Huang, Li-Ping,Liu, Chang-Ming. 2013

[8]Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes. Liu, Jianbo,Huang, Liping,Wei, Yanwu,Tang, Qinghai,Liu, Dan,Wang, Yiping,Li, Shengbin,Guo, Longjun,Wu, Hongli,Liu, Changming.

[9]Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice. Wang, Yiping,Lu, Yuehua,Liu, Dan,Wei, Yanwu,Guo, Longjun,Wu, Hongli,Huang, Liping,Liu, Jianbo,Liu, Changming.

[10]Regulatory role of ASK1 in porcine circovirus type 2-induced apoptosis. Wei, Li,Zhu, Shanshan,Wang, Jing,Zhang, Chunyan,Quan, Rong,Yan, Xv,Liu, Jue.

[11]Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys. Wang, Leyi,Qin, Zhuoming,Saifa, Yehia M.,Lee, Chang-Won,Wang, Leyi,Saifa, Yehia M.,Lee, Chang-Won,Qin, Zhuoming,Pantin-Jackwood, Mary,Faulkner, Olivia,Suarez, David L.,Garcia, Maricarmen,Lupiani, Blanca,Reddy, Sanjay M.. 2011

[12]Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV(FDDV13). Qi, Xu,Su, Zhiqiang,Wang, Xuefeng,Wang, Shuai,Lin, Yuezhi,Jiang, Chenggang,Ma, Jian,Zhao, Liping,Lv, Xiaoling,Shen, Rongxian,Kong, Xiangang,Zhou, Jianhua,Wang, Xuefeng,Wang, Fenglong,Ma, Jian. 2010

[13]Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses. Wu, Peipei,Lu, Jihu,Zhang, Xuehua,Mei, Mei,Feng, Lei,Hou, Jibo,Tang, Yinghua,Wu, Peipei,Lu, Jihu,Zhang, Xuehua,Mei, Mei,Feng, Lei,Hou, Jibo,Tang, Yinghua,Wu, Peipei,Lu, Jihu,Zhang, Xuehua,Mei, Mei,Feng, Lei,Peng, Daxin,Hou, Jibo,Liu, Xiufan,Tang, Yinghua,Peng, Daxin,Liu, Xiufan,Kang, Sang-Moo. 2017

[14]Paving the way to construct a new vaccine against Escherichia coli from its recombinant outer membrane protein C via a murine model. Wang, Xiao,Guan, Qingfeng,Wang, Xiumin,Teng, Da,Mao, Ruoyu,Wang, Jianhua,Wang, Xiao,Yao, Junhu,Wang, Xiao,Guan, Qingfeng,Wang, Xiumin,Teng, Da,Mao, Ruoyu,Wang, Jianhua. 2015

[15]Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken. Liu, Yongzhen,Li, Kai,Gao, Yulong,Gao, Li,Zhong, Li,Zhang, Yao,Liu, Changjun,Zhang, Yanping,Wang, Xiaomei. 2016

[16]Early immunocastration of male pigs with Improvac (R) - Effect on boar taint, hormones and reproductive organs. Brunius, Carl,Zamaratskaia, Galia,Lundstrom, Kerstin,Andersson, Kristina,Chen, Gang,Norrby, Mattias,Madej, Andrzej. 2011

[17]A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge. Liu, Guangliang,Zhang, Fangfang,Shi, Jianzhong,Tian, Guobing,Chen, Hualan,Yu, Kangzheng,Meng, Qingwen. 2013

[18]The Taishan Robinia pseudoacacia polysaccharides enhance immune effects of rabbit haemorrhagic disease virus inactivated vaccines. Yang, Shifa,Li, Guiming,Zhao, Zengcheng,Feng, Minyan,Fu, Jian,Huang, Zhongli,Song, Minxun,Lin, Shuqian. 2017

[19]Mucosal Immune Responses against Live Newcastle Disease Vaccine in Immunosuppressed Chickens. Yan, Zhengui,Zhao, Qingyou,Fan, Ruifeng,Guo, Wenlong,Ma, Rongde,Wang, Xinjian,Zhu, Ruiliang,Du, Yijun. 2011

[20]Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits. Guo, Huimin,Zhu, Jie,Tan, Yonggui,Li, Chuanfeng,Chen, Zongyan,Liu, Guangqing,Sun, Shiqi.

作者其他论文 更多>>

微信小程序